1Lewington S,Clarke R,Qizilbash N,et al.Age-specific relevance of usual blood pressure to vascular mortality.Lancet,2002,360:1903-1913.
2Chobanizn A V,Bakris GL,Black HR,et al.The Seventh Report of the Joint National Committee on Preveation,Detertion,Evaluation,and Treatment of High Blood Pressure:the JNC 7 report.JAMA,2003,289:2560-2572.
3Rubins HB.Triglycerides and coronary heart disease:implications of recent clinical trials.J Cardiovasc Risk,2000,7:339-345.
5Arroliga AC, Sandur S, Jacobsen DW, et al. Association between hyperhomocysteinemia and primary pulmonary hypertension.Respir Med, 2003, 97: 825-829.
6Hoieggen A, Fossum E, Reims H, et al. Serum uric acid and hemorheology in borderline hypertensives and in subjects with established hypertension and left ventricular hypertrophy. Blood Press, 2003, 12: 104-110.
7Witherell HL, Smith KL, Friedman GD, et al. C-reactive protein, Hellcobacter pylori, Chlamydia pneumonlae, cytomegalovirus and risk for myocardial infarction. Ann Epldemiol,2003, 13: 170-177.
8Ong HT. Protecting the heart: a practical review of the statin studies. Med Gen Meal, 2002, 4: 1.
9Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients withhypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.Lancet, 1998, 351: 1755-1762.
10Swales JD. Current clinical practice in hypertension: the EIS-BERG( Evaluation and Interventions for Systolic Blood Pressure Elevation-Regional and Global) project. Am Heart J, 1999,138: 231-237.
